Online Summary
Correction to: Signorovitch J, Ramakrishnan K, Ben-Hamadi R et al. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors. Curr Med Res Opin 2011;27:1089-96; doi: 10.1185/03007995.2011.567255
Correction to: Signorovitch J, Ramakrishnan K, Ben-Hamadi R et al. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors. Curr Med Res Opin 2011;27:1089-96
The authors have been made aware of an error in the table of baseline characteristics stratified by trial () that resulted in reporting baseline values for the wrong treatment groups (values from the escitalopram group were reported for the duloxetine group and vice versa). Also, the number of patients reported in the ‘Other’ race category was inaccurate.
Table 1. Baseline characteristics by trial.
This was a formatting error and did not affect the table of baseline characteristics pooled across trials (Table 2) or any of the study results or conclusions. The authors report the following which has been revised: